Compare CTKB & DGICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTKB | DGICB |
|---|---|---|
| Founded | 1990 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 652.1M | 562.0M |
| IPO Year | 2021 | N/A |
| Metric | CTKB | DGICB |
|---|---|---|
| Price | $5.04 | $16.84 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.88 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 2.9K |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 4.13% |
| EPS Growth | N/A | ★ 219.91 |
| EPS | N/A | ★ 2.38 |
| Revenue | $196,828,000.00 | ★ $987,826,105.00 |
| Revenue This Year | N/A | $2.26 |
| Revenue Next Year | $5.62 | $3.46 |
| P/E Ratio | ★ N/A | $8.29 |
| Revenue Growth | N/A | ★ 0.89 |
| 52 Week Low | $2.37 | $13.19 |
| 52 Week High | $7.30 | $20.46 |
| Indicator | CTKB | DGICB |
|---|---|---|
| Relative Strength Index (RSI) | 53.03 | 54.59 |
| Support Level | $4.71 | $15.96 |
| Resistance Level | $5.13 | $17.40 |
| Average True Range (ATR) | 0.20 | 0.29 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 79.20 | 67.44 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.